A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer
Clinical trial NCT00938652 · COMPLETED
Trial details
- NCT number
- NCT00938652
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2011-01-01
- Enrollment
- 519
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.